Alterations of cardiac structure in patients with isolated office, ambulatory, or home hypertension: Data from the general population (Pressione Arteriose Monitorate E Loro Associazioni [PAMELA] Study)

Circulation

Volumn 104, Issue 12, 2001, Pages 1385-1392

  Sega, Roberto ^a,e   Trocino, Giuseppe ^a   Lanzarotti, Arturo ^e   Carugo, Stefano ^a   Cesana, Giancarlo ^b,d   Schiavina, Riccardo ^a   Valagussa, Franco ^a   Bombelli, Michele ^a   Giannattasio, Cristina ^a   Zanchetti, Alberto ^c,d   Mancia, Giuseppe ^a,c,d  

^a SAN GERARDO HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^d ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^e ISTRA   (Italy)

Author keywords

Blood pressure; Hypertension; Hypertrophy

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE MONITORING; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ECHOCARDIOGRAPHY; FEMALE; HEART AFTERLOAD; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; WHITE COAT HYPERTENSION;

EID: 0035908944     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc3701.096100     Document Type: Article

References (35)

1. 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension
2. How common is white coat hypertension?
3. Editors' corner: White coal hypertension: Misnomers, misconceptions and misunderstandings: What should we do next?
4. The prognostic value of ambulatory blood pressure monitoring in treated hypertensive patients
5. Cardiovascular outcome in white-coat versus sustained mild hypertension: A 10-year follow-up study
6. Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: A prospective study
7. Ambulatory blood pressure: An independent predictor of prognosis in essential hypertension
8. Isolated office hypertension: A prehypertensive state?
9. Follow-up clinic and ambulatory blood pressure in untreated white-coat hypertensive patients (evaluation after 2-5 years)
10. The management and follow-up of patients with white-coat hypertension
11. White-coat hypertension: A selection bias? Hypertension and Ambulatory Recording Venetia Study
12. Diagnosis of mild hypertension by ambulatory blood pressure monitoring
13. Metabolic risk factors in white coat hypertensives
14. Is elevation of clinic blood pressure in patients with white coat hypertension who have normal ambulatory blood pressure associated with target organ changes?
15. Isolated clinic hypertension is not an innocent phenomenon: Effect on the carotid artery structure
16. Is white coat hypertension associated with arterial disease or left ventricular hypertrophy?
17. Target organ status and serum lipids in patients with white coal hypertension
18. A low-density lipoprotein oxidation and vitamins E and C in sustained and white-coat hypertension
19. Clinic-daytime blood pressure differences and cardiovascular damage
20. White-coat hypertension and target organ involvement: The impact of different cut-off levels on albuminuria and left ventricular mass and geometry
21. Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension and normotension
22. Task Force V: White-coat hypertension
23. Ambulatory blood pressure normality: Results from the PAMELA Study
24. Ambulatory and home blood pressure normality in the elderly
25. Elevated ambulatory with normal clinic pressure ("white coat normotension") is associated with cardiac and arterial organ damage
26. The Committee on M-mode standardization of the American Society of Echocardiography: Recommendations regarding quartitation in M-mode echocardiography: Results of a survey of echocardiographic measurements
27. Echocardiographic determination of left ventricular mass in man
28. A formula to estimate the approximative surface area if height and weight are known
29. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension
30. Hypertensive cardiac hypertrophy: Pathophysiologic and clinical characteristics
31. Prognosis of isolated systolic and isolated diastolic hypertension as assessed by self-measurement of blood pressure at home: The Ohasama study
32. Task Force II: Ambulatory blood pressure monitoring in population studies
33. Attenuation of the "white-coat effect" by antihypertensive treatment and regression of target organ damage
34. Blood pressure, stroke and coronary heart disease, II: Effects of short-term reductions in blood pressure: An overview of the unconfounded randomised drug trials in an epidemiological context
35. Prognostic implications of echocardlographically determined left ventricular mass in the Framingham Heart Study